A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE1
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
- Status
- RECRUITING
- Phase
- PHASE4
The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
- Status
- RECRUITING
- Phase
- NA
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
- Status
- RECRUITING
- Phase
- NA
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- N/A
Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique
- Status
- RECRUITING
- Phase
- N/A
Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
- Status
- RECRUITING
- Phase
- NA
A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE1
CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE1
A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1